Nrf2 Agonists. Given its broad effects on antioxidant responses, targeting Nrf2 directly is an appealing strategy to suppress oxidative stress and improve corticosteroid sensitivity in severe asthma and COPD. The gene discussed is NFE2L2; the disease is asthma.